BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 29633255)

  • 41. Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression.
    Raha P; Thomas S; Thurn KT; Park J; Munster PN
    Breast Cancer Res; 2015 Feb; 17(1):26. PubMed ID: 25848915
    [TBL] [Abstract][Full Text] [Related]  

  • 42. LSD1 Inhibitor T-3775440 Inhibits SCLC Cell Proliferation by Disrupting LSD1 Interactions with SNAG Domain Proteins INSM1 and GFI1B.
    Takagi S; Ishikawa Y; Mizutani A; Iwasaki S; Matsumoto S; Kamada Y; Nomura T; Nakamura K
    Cancer Res; 2017 Sep; 77(17):4652-4662. PubMed ID: 28667074
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia.
    Feng Z; Yao Y; Zhou C; Chen F; Wu F; Wei L; Liu W; Dong S; Redell M; Mo Q; Song Y
    J Hematol Oncol; 2016 Mar; 9():24. PubMed ID: 26970896
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sp1-mediated epigenetic dysregulation dictates HDAC inhibitor susceptibility of HER2-overexpressing breast cancer.
    Li G; Xie Q; Yang Z; Wang L; Zhang X; Zuo B; Zhang S; Yang A; Jia L
    Int J Cancer; 2019 Dec; 145(12):3285-3298. PubMed ID: 31111958
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The histone demethylase LSD1 is required for estrogen-dependent S100A7 gene expression in human breast cancer cells.
    Yu SE; Jang YK
    Biochem Biophys Res Commun; 2012 Oct; 427(2):336-42. PubMed ID: 23000163
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The histone demethylase LSD1 is a novel oncogene and therapeutic target in oral cancer.
    Wang Y; Zhu Y; Wang Q; Hu H; Li Z; Wang D; Zhang W; Qi B; Ye J; Wu H; Jiang H; Liu L; Yang J; Cheng J
    Cancer Lett; 2016 Apr; 374(1):12-21. PubMed ID: 26872725
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polyamine analogs modulate gene expression by inhibiting lysine-specific demethylase 1 (LSD1) and altering chromatin structure in human breast cancer cells.
    Zhu Q; Huang Y; Marton LJ; Woster PM; Davidson NE; Casero RA
    Amino Acids; 2012 Feb; 42(2-3):887-98. PubMed ID: 21805138
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lysine-Specific Demethylase 1 Affects the Progression of Papillary Thyroid Carcinoma via HIF1α and microRNA-146a.
    Long M; Zhu Y; Chen Z; Lin S; Peng X; Luo D; Li H; Tan L
    J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32303750
    [TBL] [Abstract][Full Text] [Related]  

  • 49. LSD1 promotes S-phase entry and tumorigenesis via chromatin co-occupation with E2F1 and selective H3K9 demethylation.
    He Y; Zhao Y; Wang L; Bohrer LR; Pan Y; Wang L; Huang H
    Oncogene; 2018 Jan; 37(4):534-543. PubMed ID: 28991226
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The histone deacetylase inhibitor PCI-24781 impairs calcium influx and inhibits proliferation and metastasis in breast cancer.
    Yang T; Wang P; Yin X; Zhang J; Huo M; Gao J; Li G; Teng X; Yu H; Huang W; Wang Y
    Theranostics; 2021; 11(5):2058-2076. PubMed ID: 33500709
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of LSD1 by Pargyline inhibited process of EMT and delayed progression of prostate cancer in vivo.
    Wang M; Liu X; Guo J; Weng X; Jiang G; Wang Z; He L
    Biochem Biophys Res Commun; 2015 Nov; 467(2):310-5. PubMed ID: 26435505
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HDAC is indispensable for IFN-γ-induced B7-H1 expression in gastric cancer.
    Deng R; Zhang P; Liu W; Zeng X; Ma X; Shi L; Wang T; Yin Y; Chang W; Zhang P; Wang G; Tao K
    Clin Epigenetics; 2018 Dec; 10(1):153. PubMed ID: 30537988
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oncogene LSD1 is epigenetically suppressed by miR-137 overexpression in human non-small cell lung cancer.
    Zhang X; Zhang X; Yu B; Hu R; Hao L
    Biochimie; 2017 Jun; 137():12-19. PubMed ID: 28223039
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acetylation of CCAR2 Establishes a BET/BRD9 Acetyl Switch in Response to Combined Deacetylase and Bromodomain Inhibition.
    Rajendran P; Johnson G; Li L; Chen YS; Dashwood M; Nguyen N; Ulusan A; Ertem F; Zhang M; Li J; Sun D; Huang Y; Wang S; Leung HC; Lieberman D; Beaver L; Ho E; Bedford M; Chang K; Vilar E; Dashwood R
    Cancer Res; 2019 Mar; 79(5):918-927. PubMed ID: 30643017
    [TBL] [Abstract][Full Text] [Related]  

  • 55. USF1-induced overexpression of long noncoding RNA WDFY3-AS2 promotes lung adenocarcinoma progression via targeting miR-491-5p/ZNF703 axis.
    Ren P; Hong X; Chang L; Xing L; Zhang H
    Mol Carcinog; 2020 Aug; 59(8):875-885. PubMed ID: 32275336
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The R251Q mutation of LSD1 promotes invasion and migration of luminal breast cancer cells.
    Zhang Y; Wu T; Wang Y; Zhao X; Zhao B; Zhao X; Zhang Q; Jin Y; Li Z; Hu X
    Int J Biol Macromol; 2020 Dec; 164():4000-4009. PubMed ID: 32882276
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition.
    Augert A; Eastwood E; Ibrahim AH; Wu N; Grunblatt E; Basom R; Liggitt D; Eaton KD; Martins R; Poirier JT; Rudin CM; Milletti F; Cheng WY; Mack F; MacPherson D
    Sci Signal; 2019 Feb; 12(567):. PubMed ID: 30723171
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of MDA-MB-231 breast cancer cell proliferation and tumor growth by apigenin through induction of G2/M arrest and histone H3 acetylation-mediated p21
    Tseng TH; Chien MH; Lin WL; Wen YC; Chow JM; Chen CK; Kuo TC; Lee WJ
    Environ Toxicol; 2017 Feb; 32(2):434-444. PubMed ID: 26872304
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impairment of prostate cancer cell growth by a selective and reversible lysine-specific demethylase 1 inhibitor.
    Willmann D; Lim S; Wetzel S; Metzger E; Jandausch A; Wilk W; Jung M; Forne I; Imhof A; Janzer A; Kirfel J; Waldmann H; Schüle R; Buettner R
    Int J Cancer; 2012 Dec; 131(11):2704-9. PubMed ID: 22447389
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High nuclear expression levels of histone-modifying enzymes LSD1, HDAC2 and SIRT1 in tumor cells correlate with decreased survival and increased relapse in breast cancer patients.
    Derr RS; van Hoesel AQ; Benard A; Goossens-Beumer IJ; Sajet A; Dekker-Ensink NG; de Kruijf EM; Bastiaannet E; Smit VT; van de Velde CJ; Kuppen PJ
    BMC Cancer; 2014 Aug; 14():604. PubMed ID: 25139823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.